Search research articles
Contact Us
Filters
Showing results (41-50 of 209) with videos related to
Page
of 21
Sort By:
Pediatric Nephrology (Berlin, Germany)
|
March 24, 2025
IPNA recommendations for treatment of IgA nephropathy: why there should be a greater emphasis on pathology moving forward
Mark Haas, Alexandra Cambier
Kidney International Reports
|
April 18, 2019
Transplant Glomerulopathy With Glomerular C3 Deposits: Why the Worse Outcome?
Michifumi Yamashita, Mark Haas
Kidney International
|
November 21, 2025
Seeing the light (chains): a paradigm shift in PGNMID
Jean Hou, Mark Haas
Kidney International
|
August 20, 2023
Finding the right context of use for molecular transplant diagnostics in kidney allograft biopsies
Michael Mengel, Mark Haas
Kidney International
|
February 17, 2017
Paraprotein-associated thrombotic microangiopathy: expanding the spectrum of renal disease related to plasma cell dyscrasias
Mercury Lin, Mark Haas
Clinical Journal of the American Society of Nephrology : CJASN
|
March 23, 2017
Temporal Trends in the Epidemiology of Biopsy-Proven Glomerular Diseases: An Alarming Increase in Diabetic Glomerulosclerosis
Jean Hou, Mark Haas
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Antibody-mediated rejection in renal allografts: lessons from pathology
Lorraine C Racusen, Mark Haas
Kidney International
|
May 20, 2004
Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases
Mark Haas, Joseph A Eustace
Advances in Chronic Kidney Disease
|
March 28, 2012
Morphologic markers of progressive immunoglobulin A nephropathy
Mark Haas, Heather N Reich
Journal of Clinical Medicine
|
July 9, 2022
Crescents and IgA Nephropathy: A Delicate Marriage
Hernán Trimarchi, Mark Haas, Rosanna Coppo
Page
of 21
Search research articles
Search
Showing results (41-50 of 209) with videos related to
Sort By:
Page
of 21
Pediatric Nephrology (Berlin, Germany)
|
March 24, 2025
IPNA recommendations for treatment of IgA nephropathy: why there should be a greater emphasis on pathology moving forward
Mark Haas, Alexandra Cambier
Kidney International Reports
|
April 18, 2019
Transplant Glomerulopathy With Glomerular C3 Deposits: Why the Worse Outcome?
Michifumi Yamashita, Mark Haas
Kidney International
|
November 21, 2025
Seeing the light (chains): a paradigm shift in PGNMID
Jean Hou, Mark Haas
Kidney International
|
August 20, 2023
Finding the right context of use for molecular transplant diagnostics in kidney allograft biopsies
Michael Mengel, Mark Haas
Kidney International
|
February 17, 2017
Paraprotein-associated thrombotic microangiopathy: expanding the spectrum of renal disease related to plasma cell dyscrasias
Mercury Lin, Mark Haas
Clinical Journal of the American Society of Nephrology : CJASN
|
March 23, 2017
Temporal Trends in the Epidemiology of Biopsy-Proven Glomerular Diseases: An Alarming Increase in Diabetic Glomerulosclerosis
Jean Hou, Mark Haas
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Antibody-mediated rejection in renal allografts: lessons from pathology
Lorraine C Racusen, Mark Haas
Kidney International
|
May 20, 2004
Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases
Mark Haas, Joseph A Eustace
Advances in Chronic Kidney Disease
|
March 28, 2012
Morphologic markers of progressive immunoglobulin A nephropathy
Mark Haas, Heather N Reich
Journal of Clinical Medicine
|
July 9, 2022
Crescents and IgA Nephropathy: A Delicate Marriage
Hernán Trimarchi, Mark Haas, Rosanna Coppo
Page
of 21